Many inflammatory diseases respond well to corticosteroids but their cumulative toxic effects limit how long patients can safely take them. This study tested a drug aimed at inhibiting intracellular ...
The myriad of adverse effects from corticosteroid therapy are well known to physicians, nurses, pharmacists, and patients. In general, adverse effects are dose- and time-dependent with 50% of patients ...
Today in the United States, autoimmune disease treatment continues to prioritize short-term symptom relief over long-term ...
The analysis included 1396 evaluable postmarketing adverse event reports involving EV, a nectin-4-targeting antibody-drug conjugate approved for advanced urothelial carcinoma (mean age, 70.8 years; 73 ...
John Stone, Chair of the Scientific Advisory Board at Steritas (MA, USA), lays out the issues presented by the wide-ranging use of steroid drugs and the rising prevalence of steroid-toxicity sparing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results